1. Abuchowski A, Kazo GM, Verhoest CR et al (1984) Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol asparaginase conjugates. Cancer Biochem Biophys 7(2):175–186
2. Adamson RH, Fabro S (1968) Antitumor activity and other biological properties of L-asparaginase (NSC – 109229)- a review. Cancer Chemother Rep 52(6):617–626
3. Aghaiypour K, Wlodawer A, Lubkowski J (2001) Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry 40(19):5655–5664. doi:dx.doi.org
4. Alpar HO, Lewis DA (1985) Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. Biochem Pharmacol 34(2):257–261
5. American Cancer Society (2010) Cancer facts and figure 2010. http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf